Oakland, CA, United States of America

Virginia E Paton


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 49(Granted Patents)


Location History:

  • Oakland, CA (US) (2011)
  • Piedmont, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Virginia E. Paton: Innovator in Breast Cancer Treatment

Introduction

Virginia E. Paton is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of oncology, particularly in the treatment of metastatic breast cancer. With a total of 3 patents to her name, her work has the potential to improve the lives of many patients.

Latest Patents

Virginia's latest patents focus on the treatment of previously untreated HER2-positive metastatic breast cancer. The inventions involve a combination of a growth inhibitory HER2 antibody, a HER2 dimerization inhibitor antibody, and a taxane. Specifically, her work addresses the treatment of patients who have not received prior chemotherapy or biologic therapy. The combination therapy aims to extend the survival of these patients through the administration of trastuzumab, pertuzumab, and docetaxel.

Career Highlights

Virginia E. Paton is associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. Her research and inventions have contributed to advancements in cancer treatment, showcasing her dedication to improving patient outcomes.

Collaborations

Virginia has collaborated with notable colleagues, including Anne Blackwood Chirchir and Pam Klein. These partnerships have further enhanced her research efforts and the development of her patented treatments.

Conclusion

Virginia E. Paton is a trailblazer in the field of breast cancer treatment, with her innovative patents paving the way for new therapeutic options. Her work exemplifies the impact of dedicated inventors in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…